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Abstract: Dendritic cells (DCs) represent a functionally diverse and flexible population of rare cells with the unique 
capability of binding, internalizing and detecting various microorganisms and their components. However, the re-
sponse of DCs to innocuous or pathogenic microbes is highly dependent on the type of microbe-associated molecu-
lar patterns (MAMPs) recognized by pattern recognition receptors (PRRs) that interact with phylogenetically con-
served and functionally indispensable microbial targets that involve both self and foreign structures such as lipids, 
carbohydrates, proteins, and nucleic acids. Recently, special attention has been drawn to nucleic acid receptors 
that are able to evoke robust innate immune responses mediated by type I interferons and inflammatory cytokine 
production against intracellular pathogens. Both conventional and plasmacytoid dendritic cells (cDCs and pDCs) ex-
press specific nucleic acid recognizing receptors, such as members of the membrane Toll-like receptor (TLR) and the 
cytosolic RIG-I-like receptor (RLR) families. TLR3, TLR7/TLR8 and TLR9 are localized in the endosomal membrane 
and are specialized for the recognition of viral double-stranded RNA, single-stranded RNA, and nonmethylated DNA, 
respectively whereas RLRs (RIG-I, MDA5, and LGP2) are cytosolic proteins that sense various viral RNA species. In 
this review we discuss the significance of detecting the genomic content of viruses by DC subsets capable of linking 
innate and adaptive immunity, and several viral evasion mechanisms that may allow us to better understand these 
responses. A particular attention is paid to the possible collaboration of TLR and RLR sensors in anti-viral protection.
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Introduction
Dendritic cells (DCs) play a pivotal role in bridg-
ing innate and adaptive immunity and in orches-
trating strictly controlled immune responses, 
which ensure restoration of the resting state 
and the maintenance of self tolerance, or sup-
port the generation of effector and memory 
cells. Tissue resident DCs are able to engulf 
extracellular particles and soluble material and 
by continuous sampling of their environment 
they collect the actual molecular composition 
of a given tissue. Stress, inflammation or patho-
genic evasion may alter the amount and con-
tent of the engulfed material and trigger the 
local stimulation of DCs [1]. The first response 
of tissue resident DCs to activation signals is 
the expression of cytokines, chemokines and 
their receptors followed by the rapid migration 
to secondary lymphoid organs to transport and 
present the stored material for naive circulating 
T-lymphocytes [2-4]. The nature, combination 
and duration of tissue-derived molecular sig-
nals determine the functional activities of DCs 
and have an impact on the polarization, magni-
tude, regulatory or stimulatory nature and dura-
tion of T-lymphocyte responses.
Under steady state conditions DCs are present 
throughout the body at low numbers represent-
ing ~1-2 % of white blood cells. They are charac-
terized by high versatility, flexibility and multiple 
functional activities combined with their dual 
capacity to induce self tolerance or trigger 
immune responses. They also act as the most 
efficient antigen presenting cells (APC) to acti-
vate and instruct the differentiation of inntate, 
CD4+ and CD8+ T-lymphocytes and have been 
shown to be indispensible for inducing CD8+ 
cytotoxic T-cell priming [5]. Epithelial surfaces, 
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such as the bronchial and intestinal tracts are 
continuously exposed to high doses of environ-
mental antigens and pathogens, consequently 
they are considered more tolerogenic than the 
skin or other tissues, which also can be 
attacked by infectious agents, traumatic or 
toxic shock. These environmental changes are 
monitored preferentially by mechanisms of the 
innate immune system through epithelial, 
endothelial and stromal cells in collaboration 
with tissue resident macrophages, DCs and 
mast cells [6]. To our present view, the major 
function of DCs is to alarm the immune system 
against foreign and dangerous interventions, 
and to protect self tissues from damage to 
maintain self-tolerance. Discovering the coordi-
nation of these seemingly counteracting tasks 
may open up new avenues for stimulating or 
regulating immune responses and to develop 
preventive or therapeutic interventions for 
treating inflammatory and autoimmune diseas-
es or cancer, as well as designing new types of 
vaccines based on DCs biology [7-10].
Development and specialization of human 
dendritic cell subtypes and subsets
DCs arise from bone marrow-derived CD34+ 
hematopoietic stem cells (HSC), which main-
tain their functional flexibility and are able to 
generate various DCs subsets. The two major 
subsets of DCs involve bone marrow derived 
plasmacytoid DCs (pDCs) and conventional 
DCs (cDC), which exhibit distinct phenotypic 
and functional attributes [11, 12]. Based on 
their origin DCs can be further classified as 
conventional circulating CD1c+ and CD1c- blood 
DCs and monocyte-derived DCs [13]. Further 
separation identified the rare but highly spe-
cialized CD141+ blood DC population with the 
unique capacity to cross-present viral antigens, 
the monocyte derived CX3CR1+ non-migrating 
DC subset associated to the gut epithelium, 
and CD103+ DC present in the gut lamina pro-
pria and in mediastinal lymph nodes [14]. This 
heterogeneity reflects the functional specializa-
tion of defined DC subsets and suggests a 
rational distribution of labor at the level of DCs.
By analyzing more than 200 healthy donors we 
have previously described that the ratio of the 
CD1a+ and CD1a- monocyte-derived DCs 
(moDCs) vary among individuals. Our results 
also indicated that CD1a+ and CD1a- moDCs 
differ in the expression of some phenotypic 
markers, in their internalizing capacity, and 
migratory potential to lymph node-derived che-
mokines. Furthermore, a marked difference 
was found in the production of cytokines upon 
stimulation by CD40 ligand (CD40L) or various 
Pattern Recognition Receptor (PRR) ligands 
[15, 16]. It was also shown that the ligand 
induced activation of the peroxisome prolifera-
tor-activated receptor-gamma (PPARγ), a mem-
ber of the nuclear hormone receptors, can 
skew monocyte-derived DCs differentiation 
towards the CD1a- subset. As the expression of 
CD1 molecules (CD1a, b, c) could be down reg-
ulated by PPARγ, while CD1d expression was 
increased suggested opposing regulation of 
the expression of these lipid presenting mole-
cules. In this context the pathways involved in 
this counter regulation were identified as serum 
lipids and lipoproteins, known modulators of 
PPARγ activity and consequently the dichotomy 
of CD1a- and CD1a+ cells [17]. A recent study 
confirmed our previous findings showing indi-
vidual differences in CD1a expression by dem-
onstrating CD1a deficiency as a common and 
genetically regulated phenomenon in the 
human population indicating a biologically rele-
vant regulation [18]. Our findings and these 
new results identified the CD1a membrane pro-
tein as a marker of the phenotypically and func-
tionally distinct CD1a+ DC subset.
Pattern recognition receptors of human den-
dritic cells
An important biological function of DCs relies 
on the continuous sampling of their tissue envi-
ronment, responding to stress and danger sig-
nals and transducing the collected molecular 
information to other cell types of the immune 
system. DCs are equipped with unique sets of 
phylogenetically conserved PRRs, which are 
specialized to recognize Microbe Associated 
Molecular Patterns (MAMPs) and Danger 
Associated Molecular Patterns (DAMPs) [19, 
20]. The response of DCs to MAMPs and DAMPs 
is executed by the activation of resting DCs by 
microbial components, noxious or toxic insults. 
Activation of DCs results in the expression of 
costimulatory molecules, the production of 
cytokines, chemokines and other soluble medi-
ators. Both resting and stimulated DCs are able 
to change their tissue location and migrate 
through peripheral and lymphoid tissues. 
Activation of DCs by MAMPs and DAMPS results 
in the rapid, chemokine-mediated transloca-
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tion of DCs to draining lymph nodes where they 
have the chance to contact antigen-specific 
T-lymphocytes to initiate adaptive immune 
responses [21, 22]. This process also ensures 
the transfer of molecular information collected 
in the periphery towards other cell types of both 
innate and adaptive immunity such as neutro-
phil granulocytes, NK and NKT cells, T- and 
B-lymphocytes.
The action of DCs can be divided into the recog-
nition phase followed by phases of signal trans-
duction pathways assisted by adaptors and 
mediated by posttranslational modifications 
such as phosphorylation and ubiquitination 
events leading to the activation of transcription 
factors, and gene transcription accompanied 
by the production of soluble factors [23, 24]. In 
this cascade few receptor complexes ligated by 
their specific ligands allow enormous signal 
amplification. It has also been shown that the 
generation of fully active and stable DCs 
requires the parallel activation of multiple sig-
naling pathways [25]. This suggests that sig-
nals through a single receptor may result in par-
tial activation only, which may be reverted by 
signals which favor the differentiation of regula-
tory DCs. Signals generated by Toll-like recep-
tors, cytokines, chemokines, eicosanoids, free 
oxygen radicals, and various inflammatory 
mediators all contribute to a “signaling matrix” 
and influence the phenotype and functional 
responses of DCs.
TLRs and RLRs: sensors of viral nucleic acids
The immune system acts as an evolutionally 
conserved and advanced host defense mecha-
nism against invading pathogens. Innate 
immune responses are triggered by phyloge-
netically conserved microbial components that 
are essential for the survival of a given type of 
organism. Upon pathogenic infection, these 
pathogen-associated molecular patterns (PAM- 
Ps) are recognized by specific PRRs that are 
germline encoded and are usually expressed 
constitutively in the host [26-28]. The overall 
picture however, is far more complex as suc-
cessful microbial moieties are also found in 
non-pathogenic microbes, and thus the pres-
ence of different PAMPs per se is not sufficient 
to discriminate “pathogenic” and “non-patho-
genic” life forms. Furthermore, certain PRRs 
also sense host-derived/“self” components 
that become available as a result of cellular/
tissue injury. The list of endogenous DAMPs is 
continuously growing but their impact on 
immune homeostasis are yet to be clarified. A 
recent review focuses on the role of these 
endogenous molecules in eliciting inflamma-
tion and cell death by activating innate PRRs 
[29]. Growing body of evidence also suggests 
an evolutionary link between innate immunity 
and cell death signaling. For example, several 
studies discuss the emerging role of mitochon-
dria in the activation of innate signaling, and 
the connection between apoptotic cell death 
and innate immunity [30, 31]. According to the 
symbiotic theory, the mitochondrion is an 
organelle derived from Gram-negative bacteria 
and thus the development of cellular machiner-
ies involved in cell death and innate defense 
against microbial pathogens have developed 
from ancestral mechanisms associated with 
bacteria. Thus far, five classes of PRRs have 
been identified: i) Transmembrane TLRs, which 
are integrated to cell surface or endosomal 
membranes of various cell types; ii) Membrane 
C-type lectin receptors (CLRs) characterized by 
the presence of a carbohydrate-binding domain; 
iii) Three additional families of intracellular sen-
sors, which are localized to the cytosol of vari-
ous cell types and involve NOD-like receptors 
(NLRs), RLRs, and the recently described AIM2-
like receptors (ALRs), all with nucleotide recog-
nition capabilities [32-34].
Upon binding of their specific ligands TLRs acti-
vate the NF-κB/AP-1 and the interferon-regula-
tory factor 3/7 (IRF-3/7) pathways to coordi-
nate innate and initiate adaptive immunity [35, 
36]. RLRs are essential viral sensors in the 
cytoplasm and comprise Retinoic acid induc-
ible gene-I (RIG-I), Melanoma differentiation-
associated gene-5 (MDA5), and Laboratory of 
genetics and physiology 2 (LGP2), respectively 
[37-39]. RIG-I and MDA5 have been identified 
as receptors for double-stranded RNA [40], 
Nucleotide-binding oligomerization domain (NOD)- 
like receptors mediate primarily antibacterial 
immunity through the activation of NF-kappaB 
or inflammasomes [41], whereas RIG-I-like heli-
cases have a fundamental role in the induction 
of antiviral immune responses [27]. Both RIG-I 
and MDA5 contain a C-terminal DExD/H box 
RNA helicase domain and two N-terminal cas-
pase-recruitment domains (CARDs) required for 
eliciting downstream signaling pathways, while 
LGP2 lacks the CARD-domain and acts as a pri-
mary regulator of the RIG-I/MDA5-inititated sig-
TLR and RLR signaling in dendritic cells
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naling pathway (Figure 1) [42]. RIG-I and MDA5 
have different ligand specificity but both of 
them are able to induce the production of type 
I interferons (IFNs) and pro-inflammatory cyto-
kines in a tightly regulated and balanced man-
ner [43, 44].
The TLR family is an important class of PRRs 
through which the innate immune system 
detects the major types of invasive microorgan-
isms. TLRs are also important in the non-imme-
diate phase of the immune response, such as 
the recruitment of phagocytes to infected tis-
sue areas. Recent studies revealed that TLRs 
are able to recognize several microorganisms, 
such as bacteria, fungi, protozoa, and viruses 
[45]. Once TLRs have been activated by their 
specific ligands, they trigger signal transduc-
tion cascades that mount immune responses 
through the activation of the transcription fac-
tors NF-κB, IRFs and the mitogen-activated pro-
tein kinases (MAPKs) p38, ERK1/2, and c-Jun 
N-terminal kinase (JNK). This process altogeth-
er results in the expression of a common set of 
genes whose products, such as cytokines, che-
mokines, and co-stimulatory molecules are 
essential for the orchestration of both innate 
and adaptive immunity.
Apart from the TLR “master adaptor” Myeloid 
differentiation primary response gene 88 
(MyD88), other important adaptor molecules 
Figure 1. RLR-mediated pathways of type I interferon and inflammatory responses. The interaction of dsRNA as a 
viral genome or as a replication intermediate of RNA viruses with the helicase domain of RLRs (RIG-I or MDA5) in-
duces association of the CARD domains of RIG-I/MDA5 and the adaptor protein IPS1 localized to the mitochondrial 
membrane. This receptor-adaptor interaction results in the activation of TBK1 and the subsequent phosphorylation 
of IRF3 and IRF7 on specific serine residues, resulting in their homodimerization. These dimers can translocate to 
the cell nucleus and activate the transcription of type I IFN genes. The expression of IRF3, IRF7, RIG-I and MDA5 is 
coordinately upregulated by type I IFN-mediated signaling acting as an amplification circuit. This pathway together 
with IPS1 is coupled to the NF-κB signaling pathway through the interaction of FADD (FAS-associated via death do-
main), RIP1, and TRAF6 resulting in the induction of inflammatory cytokine genes, such as IL-1β, IL-6 and TNFα. The 
TRIM proteins shown act as specific regulators of this pathway.
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also take part in downstream TLR signaling 
events: i) the MyD88-adapter-like or TIR 
domain-containing adapter (TIRAP/Mal); ii) the 
TIR domain-protein TRIF/TICAM-1; iii) the TRIF-
related adapter molecule (TRAM) also known 
as TICAM-2; iv) the protein that contains sterile 
α and HEAT-Armadillo motifs (SARM). As not all 
members of the TLR family bind the same 
adapter(s), their differential contribution en- 
sures the initiation of separate signaling cas-
cades triggered by different TLRs (Figure 2). A 
good example is the regulation of IRF3 via the 
adapter TRIF, that can be induced only by TLR3 
or TLR4 to initiate the TRIF-dependent activa-
tion of IRF3 and thereby the production of type 
I IFNs. TLR3 activation is linked to both IRF3 
and IRF7 however, the baseline expression 
level of IRF3 in DCs and in most cells is far high-
er than that of IRF7, and thus the primary target 
of TLR3-mediated activation is IRF3 [36, 46, 
47], whereas the ligation of TLR7, TLR8, and 
TLR9 triggers IRF7 activation (Figure 2). 
Signaling through TLRs in DCs leads to pro-
inflammatory cytokine and IFN responses and 
results in the recruitment of other inflammatory 
cell types such as granulocytes and natural 
killer (NK) cells. Thus, the coordinated activa-
tion and interaction of different cell types 
involved in the mobilization of innate immune 
cells are able to create a local microenviron-
ment that allows the regulated activation of 
adaptive immunity [48]. As various TLRs are 
expressed in a cell type specific manner and a 
given cells may express at least one or a 
defined combination of TLRs, these receptors 
and their adaptors may have evolved to act as 
regulators of physiological functions upon 
responding to hazardous signals [49].
Figure 2. The interplay of TLR and RLR signaling. TLRs expressed on the cell surface or localized on intracellular 
membranes recognize various sets of pathogenic structures among them viral genomes or replication intermedi-
ates and transduce signals through the NF-κB/type I IFN pathways. The TLR3 and TLR4 mediated signaling path-
ways are independent of MyD88 and IRAKs (IRAK-1/2/4), whereas the other TLRs use the MyD88 pathway. TLR4 is 
capable of using both MyD88-dependent and independent signaling. TRAF3 and TRAF6 have a cardinal role in both 
the collaboration and the essential signaling processes of TLRs and RLRs.
TLR and RLR signaling in dendritic cells
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Table 1. Examples of viruses detected by RLRs
RIG-I MDA5
Taxonomy Paramyxoviruses: Picornaviruses:
Measles virus, Mumps virus, Respiratory 
syncytial virus
Encephalomyocarditis virus, Mengo virus, 
Theiler’s virus
Orthomyxoviruses: Reoviruses:
Influenza virus (type A, B and C), Thogotovirus Reovirus, Rotavirus
Rhabdoviridae:
Rabies virus, Vesicular stomatitis virus 
Flaviviruses:
Japanese encephaltis virus 
Type of nucleic acid ssRNA dsRNA
Several studies have revealed the importance 
of TLR-independent virus sensing mechanisms 
occurring in the cytoplasm. It is known that 
TLR7 and TLR9 are crucial endosomal detec-
tors of viral nucleic acids in plasmacytoid den-
dritic cells (pDCs), but several cell types recog-
nize viral RNA through the RLR system [50]. 
Initially, both RIG-I and MDA5 were thought to 
recognize viral dsRNA of the same type. Recent 
studies however, have shown differential recog-
nition of viral PAMPs by RIG-I and MDA5. 
According to Hornung et al., the main ligand for 
RIG-I is ssRNA with a 5’triphosphate motif [51], 
but this helicase can also be activated by short 
dsRNA fragments [52]. 5’pppRNA is a general 
genome constituent or the product of in vitro 
transcripts of most RNA viruses. Endogenous 
5’ppp moieties are removed by adding a 
7-methyl-guanosine cap in host cells, therefore 
these self-patterns are refractory to detection 
by RIG-I. In addition, the recognition of 5’ppp- 
RNA is strictly dependent on the presence of a 
short double-stranded section of the molecule, 
because short dsRNAs trigger RIG-I only weakly 
and a single 5’ppp strand by itself is unable to 
do so. It was also demonstrated that the trans-
fection of AT-rich dsDNA (synthetic polyd- 
AdT:polydAdT) leads to the production of type I 
IFNs. This phenomenon was shown to be RIG-I-
dependent and mediated by a host DNA-
dependent RNA polymerase III that transcribes 
polydAdT:polydAdT to 5’pppRNA [53, 54]. This 
latter mechanism may explain IFN induction by 
some DNA viruses and intracellular bacteria. A 
recent study reported that besides RIG-I, PKR 
can also recognize the 5’ppp signature howev-
er, this interaction does not lead to IFN produc-
tion and hence the biological significance of 
this simultaneous activation is still obscure 
[55].
MDA5 is turned out to be the key intracellular 
sensor for longer viral dsRNAs capped by di- or 
mono-5’phosphate moieties and for the nucleo-
tide-analogue poly I:C [56]. RIG-I and MDA5 
respond differently to viral infections by various 
strains: RIG-I mainly senses viruses with short 
ssRNA genome such as those exhibited by 
paramyxoviruses or orthomyxoviruses, while 
MDA5 can be activated for example by picorna-
viruses, which produce large amounts of dsRNA 
during their replication (Table 1) [39, 57]. Since 
host RNAs are single stranded (ssRNAs) capped 
by a methylguanosine or are protected by 
monophosphate at the 5’end, they do not acti-
vate RIG-I/MDA5 ensuring the discriminative 
recognition of self and foreign RNA. The third 
member of the RLR family, LGP2 lacks the 
CARD domain and is unable to activate IFN and 
pro-inflammatory cytokine responses upon 
viral stimuli, so it was originally considered act-
ing as a negative regulator of RIG-I/MDA5 [58, 
59]. A recent study by Satoh and colleagues 
showed that LGP-/- mice produce decreased 
amounts of IFN upon infection by Vesicular sto-
matitis virus (VSV) or Encephalomyocarditis 
virus (EMCV) suggesting that LGP2 may cooper-
ate with RIG-I and MDA5 to sense viral nucleic 
acids in the cytoplasm [60]. The Janus-faced 
activity of LGP2 through inhibiting and/or facili-
tating RLR activity is still a subject of contro-
versy. Furthermore, very recently LGP2 was 
shown to regulate CD8+ cytotoxic T lymphocyte 
(CTL) survival and fitness during the clonal 
expansion of lymphocytes provoked by viral 
infection. This effect was mediated via T-cell 
receptor signaling inducing the expression of 
LGP2 in CTLs [61].
Interaction of the specific ligand with the heli-
case domain of RIG-I or MDA5 induces the 
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ubiquitin-dependent association of CARD of 
RLR with the CARD domain of the CARD-adaptor 
protein inducing interferon-β (CARDIF, also 
known as IPS-1, MAVS or VISA), which is local-
ized in the mitochondrial membrane [62, 63].
This receptor-adaptor interaction results in the 
activation of TANK-binding kinase 1 (TBK1) 
through TRAF-family-member-associated NF-κB 
activator (TANK) binding. Activated TBK1 induc-
es the phosphorylation of IRF3/IRF7 on specif-
ic serine residues, resulting in their homodi-
merization [64]. These dimers then translocate 
to the nucleus and activate the transcription of 
type I IFN genes (Figure 1). The expression of 
IRF3, IRF7, RIG-I and MDA5 is coordinately 
upregulated by type I IFN-mediated signaling 
acting as an amplification process. This path-
way is implicated to be connected to the NF-κB 
activation pathway through the interaction of 
FADD (FAS-associated via death domain), 
Receptor-interacting protein (RIP1) and TNFR-
associated factor 6 (TRAF6) together with 
CARDIF, which results in the induction of proin-
flammatory cytokine genes and proteins such 
as IL-1β, IL-6 and TNF-α (Figure 1) [65].
Lately, another protein, known as Stimulator of 
IFN genes (STING) has been described, which is 
located in the endoplasmic reticulum (ER) 
membrane [66]. STING acts as a co-factor of 
RIG-I-CARDIF, but not in MDA5-CARDIF signal-
ing. Another group of proteins, called the tripar-
tite motif-containing (TRIM) superfamily also 
play a significant role in RIG-I/MDA5 regulated 
induction of type I IFNs and of pro-inflammatory 
cytokines. TRIM proteins are expressed in 
response to IFNs and take part in many biologi-
cal processes connected to innate immunity 
[67]. For instance, TRIM27 interacts with inhibi-
tor of NF-κB (IκB) kinases (IKKs) and are able to 
block the activation of NF-κB, IRF3 and IRF7. 
Another member of the TRIM family, TRIM25 
binds to RIG-I and conjugates ubiquitin to the 
CARD domain of the helicase thus facilitating 
the activation of downstream signaling path-
ways (Figure 1) [68, 69].
Viral evasion mechanisms of TLR and RLR 
recognition and signaling
Taken the diversity of receptors specialized for 
nucleic acid recognition the genetic material 
seems to be a phylogenetically validated and 
important target of recognition. Nucleic acids 
derived from microbial genomes generated 
during viral or bacterial life-cycles are potent 
ligands for PRRs. To ensure escape from imme-
diate recognition, various pathogens developed 
numerous alternatives of evasion mechanisms 
[27]. RNA viruses, such as poxviruses are able 
to integrate into the mRNA processing appara-
tus of host cells in order to cap their viral 
mRNAs or like picornaviruses can protect their 
own genomic RNA with a covalently linked pro-
tein at the 5’end [70]. The genomic RNA of 
ssRNA viruses (like influenza A virus) possess a 
5’end triphosphate motif and therefore effi-
ciently activate the RIG-I pathway. Viruses with 
a dsRNA genome or with dsRNA as a replicative 
intermediate (positive-sense RNA viruses) are 
main targets of MDA5. Moreover, DNA viruses 
can produce high amounts of dsRNA and con-
sequently trigger an RLR-related response. In 
order to avoid recognition, some viruses encode 
protective dsRNA-binding proteins, like the 
HIV-1 Tat or VACV E3L, which can defend dsRNA 
species from detection by cytoplasmic recep-
tors [71].
RLR signaling can also be the target of viral 
evasion mechanisms mediated either by direct 
blocking of helicases or by inhibition of other 
members of the signaling cascade [72]. 
According to Mibayashi et al. the influenza A 
virus NS1 protein can block downstream signal-
ing upon binding to the RIG-I-IPS1 complex 
[73], while poliovirus can induce the degrada-
tion of MDA5 by caspase-related enzymatic 
cleavage [74]. The elimination of IPS1 is a 
„common” target of viral proteins, e.g. the hep-
atitis A 3ABC protein triggers the degradation 
of IPS1, thus decoupling the signaling cascade 
from RLRs and IRF3 [75]. The downstream 
branches of the RLR and TLR signaling path-
ways can also be blocked and the transcription-
al control of the ifnb promoter by IRFs can also 
be inhibited by several ways. The V proteins of 
paramyxoviruses behave as a mimic of IRF3 
and act as a competitve antagonist for phos-
phorylation by TBK1 [76]. Another example is 
the Kaposi’s sarcoma-associated herpesvirus 
(KSHV) viral mimic IRF7 protein, which can 
dimerize with cellular IRF7 consequently inhib-
iting its DNA-binding ability [77], whereas the 
KSHV protein K-bZIP is known as a strong inhib-
itor of IFNβ expression by competing the bind-
ing of host IRF3 to the promoter site [78]. Other 
type of viral control of IRFs is mediated by e.g. 
the rotavirus non-structural protein 1 (NSP1), 
TLR and RLR signaling in dendritic cells
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which targets IRF3, IRF5, and IRF7 for degrada-
tion [79]. Thus the cytoplasmic level of IRFs can 
be dynamically regulated by various viral fac-
tors. A putative function of the IFN-stimulated 
protein of 15kDa (ISG15) is to prevent the virus-
mediated degradation of IRFs when it binds to 
and stabilizes of IRF3 in Newcastle disease 
virus infections [80].
The role and control of the NF-κB pathway dur-
ing viral infection is far more complex than that 
of IRF3/IRF7 [27]. NF-κB is an important factor 
not only in the production of several cytokines 
and anti-viral IFNs but also able to inhibit apop-
tosis and foster cell proliferation, which effects 
are apparently beneficial to virus replication. In 
fact, some viruses activate NF-κB signaling in 
order to avoid apoptotic death of the host cell 
[81]. An example of the unique viral regulation 
of NF-κB pathway is the African swine fever 
virus (ASFV) protein A238L that inhibits NF-κB 
activity at the early stage of infection to delay 
provocation of the innate immune response 
[82]. However, at the late stage of viral infection 
another ASFV protein, called A224L activates 
NF-κB and deactivates caspases [83]. Similarly, 
the KSHV protein K13 can interact with the 
IKK-complex and accordingly is able to activate 
the NF-κB pathway [84]. This biphasic mode of 
action allows the virus to propagate in a more 
efficient manner. By the early inhibition of 
NF-κB the virus gains time to establish a sup-
portive environment for infection. Later, the 
virus has an impact on the regulation of PRR-
induced signaling-related factors and promotes 
the activation of NF-κB, thereby promoting fast 
multiplication. Referring to Bowie et al., one of 
the key challenges in future research is to har-
ness the information learned from viral evasion 
studies for the benefit of human health [27].
Interaction of TLR- and RLR-mediated path-
ways: to impel or to labefy?
The collaboration of PRRs and the consequent 
secretion of type I interferons and inflammatory 
cytokines can be highly efficient against patho-
gens. After viral infections, innate defense 
mechanisms are activated promptly and allow 
the development of adaptive immune respons-
es. DCs play an essential role in the orchestra-
tion of humoral and cellular immunity and the 
induction and maintenance of long-term immu-
nological memory [36, 85]. Interaction of 
microbes with the innate immune system 
involves the induction of multiple PRR path-
ways triggered simultaneously by various 
PAMPs of the whole pathogen [86].
The possible interaction of two or more signal-
ing pathways in biochemical systems can either 
be potentiating (synergistic) or weakening (com-
petitive, hampering). Multiple evidences have 
been accumulated in the past few years that 
reflect the enormous complexity of these pro-
cesses. For instance in moDCs and monocyte-
derived Langerhans cells (moLCs) co-ligation of 
TLR3/TLR7 and TLR3/Dectin-1 led to increased 
Th1/Th17 responses, in contrast to TLR3 and 
Langerin ligation, which had an opposite effect 
[87]. Similarly, another group found that RLR/
TLR co-activation caused decreased Th1/Th17 
responses upon bacterial infection [88]. This 
cross-interference of RLR and TLR signaling 
might have important implications in the design 
of future vaccination strategies, and the possi-
ble spectrum may be expanded to other non-
immune cell types as well [89, 90]. miRNAs 
also possess the capability of fine tuning TLR 
and RLR signaling [91]. Common regulatory 
members of both pathways such as miR-146 
can have a strong impact on the counter-regu-
lation of activation mediated by TLRs and RLRs.
The interplay between TLRs and RLRs also has 
an important role during in vivo viral infections. 
Infection by RNA viruses is detected by RLRs 
and TLR7/8 resulting in the production of type I 
IFNs (Figure 2). Kumagai and colleagues found 
that in Newcastle disease virus (NDV) infected 
mice the major source of type I IFN was not 
pDCs [92], even though they were able to pro-
duce vast amounts of IFNs in the absence of 
alveolar macrophages (AM) suggesting that 
pDCs play an important role when the first line 
of AM-mediated defense is disrupted. Since 
many viruses evolved RLR evasion mecha-
nisms, pDCs may function as a backup for anti-
viral immunity when RLR signaling is shut down 
[45]. Detection of Hepatitis C virus (HCV) is car-
ried out by both TLR3 and RIG-I but the virus 
evades type I IFN responses by expressing a 
viral protein called NS3-NS4A. This HCV prote-
ase cleaves TRIF and IPS1 and renders hepato-
cytes incapable of producing IFNβ [93]. On the 
other hand the presence of HCV induces a 
robust type I IFN response by pDCs, which infil-
trate the liver during infection. HCV RNA is deliv-
ered to pDCs by a direct cell-to-cell contact 
between infected hepatocytes and pDCs. This 
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process leads to type I IFN production via TLR7. 
Moreover, stimulation of TLR7 or TLR9 by selec-
tive ligands can also upregulate the cytoplas-
mic expression of RIG-I protein in pDCs in a 
type I IFN-independent manner showing the 
importance of collaborative signaling between 
these two PRR families (Szabo et al. unpub-
lished results).
While these sensors were shown to be crucial 
for innate and adaptive host defense, their 
inappropriate activation has been associated 
with autoimmunity and inflammatory diseases. 
Hence, a more complete appreciation of TLRs, 
RLRs, and their complex signaling processes 
will provide important insights into new thera-
peutic modalities that can either enhance 
immune responses or inhibit functions to dimin-
ish the deleterious effects of uncontrolled 
inflammation [94].
An interesting contemporary approach to the 
topic has been carried out by using systems 
biology, bioinformatics, and biophysics, as tools 
of better understanding. This approach pro-
posed that instead of single cell analyses one 
should move towards a more holistic under-
standing of signaling systems. The meta-net-
work of biological entities is considered to pos-
sess both microscopic and macroscopic 
dynamics as observed in physical sciences. 
The origin of averaging effects from stochastic 
responses of a single cell when collected to 
form a population should also be taken into 
account [95, 96]. It is very likely that the emer-
gence of an average cell deterministic response 
(e.g. following a TLR and/or RLR stimulus) from 
single cell stochastic responses complement 
each other [97, 98]. Thus the stochastic fluctu-
ations in the IFN response of a single dendritic 
cell or a single signaling pathway are necessary 
to induce probabilistic differentiation from 
identical cells or interacting pathways of the 
same PRR family. This might allow multicellular 
organisms or complex, interacting PRR signal-
ing networks to switch cell fates or states to 
yield diversity, fine-tuning and reach the proper 
response that cannot be achieved by a purely 
deterministic system. Recent studies of multi-
component, non-linear modeling of different 
TLR pathways verified the success of this 
approach [98, 99] by identifying cross-talk 
mechanisms between the MyD88- and TRAM-
dependent pathways and led to the concept of 
signaling flux redistribution (SFR). This proposal 
is based on the law of conservation where the 
removal of MyD88 leads to increased activa-
tion of the entire alternative TRAM-pathway. 
Thus, total signaling flux information from a 
receptor through final downstream gene activa-
tion in the network is conserved. The group 
experimentally validated the SFR theory by 
using MyD88-/- and TRAF6-/- KO mice and their 
data generated interesting interpretations [99], 
which may open up new aspects towards the 
deeper understanding of cellular signaling 
processes.
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